Gianluca Campo to Risk Factors
This is a "connection" page, showing publications Gianluca Campo has written about Risk Factors.
Connection Strength
0.151
-
The Assessment of Scales of Frailty and Physical Performance Improves Prediction of Major Adverse Cardiac Events in Older Adults with Acute Coronary Syndrome. J Gerontol A Biol Sci Med Sci. 2020 05 22; 75(6):1113-1119.
Score: 0.026
-
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study. JACC Cardiovasc Interv. 2019 10 28; 12(20):2079-2088.
Score: 0.025
-
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study). J Invasive Cardiol. 2018 Apr; 30(4):133-137.
Score: 0.023
-
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19. Atherosclerosis. 2021 07; 328:136-143.
Score: 0.007
-
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):203-210.
Score: 0.007
-
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Circ Cardiovasc Interv. 2019 09; 12(9):e007705.
Score: 0.006
-
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: Systematic review and individual patient pooled meta-analysis. Clin Cardiol. 2019 Mar; 42(3):358-364.
Score: 0.006
-
One-Year Results Following a Pre-Specified ABSORB Implantation Strategy in ST-Elevation Myocardial Infarction (BVS STEMI STRATEGY-IT Study). Cardiovasc Revasc Med. 2019 08; 20(8):700-704.
Score: 0.006
-
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates. Int J Cardiol. 2019 Feb 15; 277:60-65.
Score: 0.006
-
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial. EuroIntervention. 2018 03 20; 13(16):1939-1945.
Score: 0.006
-
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial). EuroIntervention. 2018 01 20; 13(13):1561-1564.
Score: 0.006
-
A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Study. JACC Cardiovasc Interv. 2017 09 25; 10(18):1855-1864.
Score: 0.006
-
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial. EuroIntervention. 2017 Aug 04; 13(5):e557-e563.
Score: 0.005
-
Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation. Am J Cardiol. 2017 Nov 01; 120(9):1460-1466.
Score: 0.005
-
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study. JACC Cardiovasc Interv. 2017 07 10; 10(13):1375-1377.
Score: 0.005
-
Mechanistic Role of mPTP in Ischemia-Reperfusion Injury. Adv Exp Med Biol. 2017; 982:169-189.
Score: 0.005